Nair, B., van Rhee, F., Shaughnessy, J. D., Anaissie, E., Szymonifka, J., Hoering, A., . . . Barlogie, B. (2010). Superior results of Total Therapy 3 (2003-33) in gene expression profiling–defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance. American Society of Hematology.
Styl ChicagoNair, Bijay, et al. Superior Results of Total Therapy 3 (2003-33) in Gene Expression Profiling–defined Low-risk Multiple Myeloma Confirmed in Subsequent Trial 2006-66 With VRD Maintenance. American Society of Hematology, 2010.
Citace podle MLANair, Bijay, et al. Superior Results of Total Therapy 3 (2003-33) in Gene Expression Profiling–defined Low-risk Multiple Myeloma Confirmed in Subsequent Trial 2006-66 With VRD Maintenance. American Society of Hematology, 2010.